levofloxacin and Obesity, Morbid
levofloxacin has been researched along with Obesity, Morbid in 5 studies
Research
Studies (5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Booker, C; Jacobson, R; Khalid, S; Omotosho, P; Terranella, S; Torquati, A | 1 |
Cerqueira, RM; Correia, M; Manso, MC; Vilar, H | 1 |
Cojutti, P; Pai, MP; Pea, F | 1 |
Colino, CI; Ferrer, A; Grau, S; Luque, S; Valle, M | 1 |
Cerqueira, RM; Correia, MR; Fernandes, CD; Manso, MC; Vilar, H | 1 |
Other Studies
5 other study(ies) available for levofloxacin and Obesity, Morbid
Article | Year |
---|---|
The Impact of Perioperative Antibiotic Prophylaxis on Weight Loss Following Laparoscopic Sleeve Gastrectomy.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bariatric Surgery; Cefoxitin; Female; Gastrectomy; Humans; Laparoscopy; Levofloxacin; Male; Metronidazole; Middle Aged; Obesity, Morbid; Postoperative Period; Retrospective Studies; Treatment Outcome; Weight Loss | 2020 |
Cumulative Helicobacter Pylori Eradication Rates by Adopting First- and Second- Line Regimens Proposed by the Maastricht IV Consensus in Obese Patients Undergoing Gastric Bypass Surgery.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Consensus; Drug Therapy, Combination; Female; Gastric Bypass; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Obesity, Morbid; Prospective Studies; Proton Pump Inhibitors; Young Adult | 2018 |
Levofloxacin dosing regimen in severely morbidly obese patients (BMI ≥40 kg/m(2)) should be guided by creatinine clearance estimates based on ideal body weight and optimized by therapeutic drug monitoring.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Area Under Curve; Bayes Theorem; Body Mass Index; Body Surface Area; Databases, Factual; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Ideal Body Weight; Kidney Function Tests; Levofloxacin; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Monte Carlo Method; Obesity, Morbid; Severity of Illness Index; Young Adult | 2014 |
Levofloxacin weight-adjusted dosing and pharmacokinetic disposition in a morbidly obese patient.
Topics: Anti-Bacterial Agents; Body Weight; Humans; Infusions, Intravenous; Levofloxacin; Middle Aged; Obesity, Morbid; Ofloxacin; Pneumococcal Infections | 2011 |
Cumulative Helicobacter pylori eradication therapy in obese patients undergoing gastric bypass surgery.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastric Bypass; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Obesity, Morbid; Ofloxacin; Portugal; Practice Guidelines as Topic; Proton Pump Inhibitors; Risk Factors; Stomach Neoplasms; Surgical Wound Infection; Treatment Failure; Young Adult | 2013 |